Moderna CEO updates timing for COVID-19 vaccine trial results
More than 25,000 people are enrolled in the drugmaker's late-stage trial of a potential coronavirus vaccine.
More than 25,000 people are enrolled in the drugmaker's late-stage trial of a potential coronavirus vaccine.